Hartshorn J N, Robison S H
Department of Neurology, University of Vermont, Burlington 05401.
Mutat Res. 1990 May-Jul;237(3-4):153-64. doi: 10.1016/0921-8734(90)90021-i.
In vitro cultures of human peripheral blood lymphocytes, both unstimulated G0 cells as well as phytohemagglutinin (PHA) stimulated cells, have been used in the investigation of DNA repair following different types of damage, including that induced by ultraviolet light, ionizing radiation, and chemical agents. We report here repair of DNA damage in cultured normal human T-lymphocytes after treatment with the alkylating agents, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) or methanesulfonate (MMS), as measured by the alkaline elution technique. T-lymphocytes cultured with different sources of T-cell growth factors (TCGFs) were shown to have similar repair levels, as measured by loss of single-strand breaks. However, diminished repair was observed with in vitro culture age when T-cells were cultured with PHA and TCGF for a 3-week period. Cell-cycle analysis performed on asynchronously growing cultures indicated that differential repair with in vitro aging was not cell-cycle-related. Fluorescence Activated Cell Sorting (FACS) was used to determine the percentages of CD4+ and CD8+ T-cell subsets present during the in vitro culture periods. Cultures consisted primarily of CD4+ cells until day 20 when the percentage of CD8+ cells increased to approximately 50% of the T-cell population. Neither the absolute percentages of CD4+ and CD8+ cells not the CD4+/CD8+ ratios correlated with repair rates of cultured T-cells. Therefore, the observed decreases in the repair of alkylating agent-induced damage are not due solely to the change in the CD4+/CD8+ ratio.
人类外周血淋巴细胞的体外培养,包括未受刺激的G0细胞以及经植物血凝素(PHA)刺激的细胞,已被用于研究不同类型损伤后的DNA修复,这些损伤包括紫外线、电离辐射和化学试剂诱导的损伤。我们在此报告,通过碱性洗脱技术测定,用烷化剂N-甲基-N'-硝基-N-亚硝基胍(MNNG)或甲磺酸酯(MMS)处理后,培养的正常人T淋巴细胞中DNA损伤的修复情况。用不同来源的T细胞生长因子(TCGF)培养的T淋巴细胞,通过单链断裂的损失来衡量,显示出相似的修复水平。然而,当T细胞用PHA和TCGF培养3周时,随着体外培养时间的延长,修复能力下降。对异步生长的培养物进行的细胞周期分析表明,体外老化导致的差异修复与细胞周期无关。荧光激活细胞分选(FACS)用于确定体外培养期间CD4+和CD8+ T细胞亚群的百分比。培养物在第20天之前主要由CD4+细胞组成,此时CD8+细胞的百分比增加到T细胞群体的约50%。CD4+和CD8+细胞的绝对百分比以及CD4+/CD8+比率均与培养的T细胞的修复率无关。因此,观察到的烷化剂诱导损伤修复的下降并非仅由于CD4+/CD8+比率的变化。